The Scientist

» preclinical

Most Recent

image: TS Picks: February 11, 2016

TS Picks: February 11, 2016

By | February 11, 2016

Reproducibility edition

0 Comments

image: In Situ Antibodies

In Situ Antibodies

By | February 2, 2016

Compared with systemic injections, localized antibody therapies may be more effective for some indications.

2 Comments

image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

3 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

image: Ebola Vaccines Protect Monkeys

Ebola Vaccines Protect Monkeys

By | April 9, 2015

Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.

0 Comments

image: NIH to Close Sex Gap in Preclinical Research

NIH to Close Sex Gap in Preclinical Research

By | May 15, 2014

The funding agency will require grant applicants to address sex balance in all future cell and animal studies.

0 Comments

image: Opinion: Pairing Discovery with Regulatory Rigor

Opinion: Pairing Discovery with Regulatory Rigor

By | May 13, 2014

To move cell-based therapies into the clinic, academic researchers may benefit by consulting researchers outside of academia and the biopharma industry.

0 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

image: Report Card: Sharing Animal Research

Report Card: Sharing Animal Research

By | January 8, 2014

New analysis finds that funding agencies, scientists, and journals are not including sufficient information when reporting on in vivo experiments.

0 Comments

Popular Now

  1. Exercise Boosts Telomere Transcription
  2. Classic Example of Symbiosis Revised
  3. The Genetic Components of Rare Diseases
  4. Orangutan Imitates Human Speech
RayBiotech